Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose-finding for prevention of emergence agitation after pediatric tonsil/adenoid surgery
ChiCTR-OIh-17011790Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in Emergence agitation (EA), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Pediatric Anesthesia Emergence Delirium score, Time to extubation and 4 more. Planned start Jul 2017; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR-OIh-17011790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIh-17011790.